type 2 diabetes with lower extremity atherosclerosis
Conditions
Interventions
Control group:placebo
Sponsors
Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Those who voluntarily participate in the trial and sign the informed consent form; 2. Aged 35 to 65 years old; 3. In line with the diagnosis of Western medicine type 2 diabetes and TCM syndrome diagnosis and lower extremity atherosclerosis.
Exclusion criteria
Exclusion criteria: 1. Patients with heart and kidney dysfunction, acute coronary syndrome, cerebrovascular accident, hematopoietic disorders and mental illness; 2. Patients with acute metabolic disorders such as diabetic ketoacidosis within the past 1 month; 3. Pregnant women, lactating women; 4. Severe infection in the past 1 month; 5. Patients with allergic constitution; 6. Uncooperative in run-in period; 7. Having a history of alcoholism or drug abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| arterial color Doppler ultrasound; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average blood glucose level;Standard deviation of mean blood glucose;Maximum blood glucose fluctuation;Insulin resistance index(Homa-IR(CP));Islet function index(islet(CP));Area under the glucose curve(SG);Area under the C-peptide curve(SCP);Glycated hemoglobin;Glucagon-like peptide-1;Blood lipid;C-reactive protein;Interleukin-6;Neutrophil lymphocyte ratio;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactYa Liu
Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed